Literature DB >> 15154948

Diabetes mellitus as a risk factor for primary open-angle glaucoma: a meta-analysis.

S Bonovas1, V Peponis, K Filioussi.   

Abstract

AIM: The association of diabetes mellitus with primary open-angle glaucoma has been controversial. The study aimed to examine the strength of this association through a detailed meta-analysis of studies published in peer-reviewed journals.
METHODS: A comprehensive search for articles published through 2002 was performed and data were abstracted. Prior to meta-analysis, all studies were evaluated for publication bias and heterogeneity. Pooled odds ratio (OR) was calculated using the random and the fixed-effects model.
RESULTS: Twelve studies published between 1987 and 2001 were included (five case-control studies and seven cross-sectional studies). Significant heterogeneity among the studies was detected (P = 0.023). No evidence of publication bias was found (P = 0.37). The association of diabetes mellitus with primary open-angle glaucoma was statistically significant assuming either a random effects [OR = 1.50, 95% confidence interval (CI) 1.16, 1.93], or a fixed-effects model (OR = 1.27, 95% CI 1.10, 1.45).
CONCLUSIONS: Our meta-analysis results suggest that diabetic patients are at significantly increased risk of developing primary open-angle glaucoma. Clinicians should be aware of this possibility.

Entities:  

Mesh:

Year:  2004        PMID: 15154948     DOI: 10.1111/j.1464-5491.2004.01173.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  44 in total

1.  The relationship between statin use and open-angle glaucoma.

Authors:  Joshua D Stein; Paula Anne Newman-Casey; Nidhi Talwar; Bin Nan; Julia E Richards; David C Musch
Journal:  Ophthalmology       Date:  2012-06-21       Impact factor: 12.079

Review 2.  The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy.

Authors:  David B Rein; John S Wittenborn; Xinzhi Zhang; Benjamin A Allaire; Michael S Song; Ronald Klein; Jinan B Saaddine
Journal:  Health Serv Res       Date:  2011-04-14       Impact factor: 3.402

3.  Relationship of incident glaucoma versus physical activity and fitness in male runners.

Authors:  Paul T Williams
Journal:  Med Sci Sports Exerc       Date:  2009-08       Impact factor: 5.411

4.  A prospective study of diabetes, lifestyle factors, and glaucoma among African-American women.

Authors:  Lauren A Wise; Lynn Rosenberg; Rose G Radin; Cynthia Mattox; Erynn B Yang; Julie R Palmer; Johanna M Seddon
Journal:  Ann Epidemiol       Date:  2011-06       Impact factor: 3.797

5.  Interaction between XRCC 1 gene polymorphisms and diabetes on susceptibility to primary open-angle glaucoma.

Authors:  Yanyan Wang; Chenguang Wang; Shounan Qi; Zaoxia Liu; Guanfang Su; Yajuan Zheng
Journal:  Exp Biol Med (Maywood)       Date:  2019-04-11

Review 6.  Effects of antiglaucoma drugs on blood flow of optic nerve heads and related structures.

Authors:  Chihiro Mayama; Makoto Araie
Journal:  Jpn J Ophthalmol       Date:  2013-01-16       Impact factor: 2.447

7.  Type 2 diabetes mellitus and the risk of open-angle glaucoma the Los Angeles Latino Eye Study.

Authors:  Vikas Chopra; Rohit Varma; Brian A Francis; Joanne Wu; Mina Torres; Stanley P Azen
Journal:  Ophthalmology       Date:  2007-08-22       Impact factor: 12.079

8.  Measurement of lamina and prelaminar thicknesses of both eyes in patients with unilateral branch retinal vein occlusion.

Authors:  Yengwoo Son; Seungwoo Lee; Jongyeop Park
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-09-14       Impact factor: 3.117

Review 9.  Ocular disease, knowledge and technology applications in patients with diabetes.

Authors:  Jennifer Threatt; Jennifer F Williamson; Kyle Huynh; Richard M Davis; Kathie Hermayer
Journal:  Am J Med Sci       Date:  2013-04       Impact factor: 2.378

10.  Diabetes, glycemic control and risk of medical glaucoma treatment: A population-based case-control study.

Authors:  Lotte G Welinder; Anders H Riis; Lars L Knudsen; Reimar W Thomsen
Journal:  Clin Epidemiol       Date:  2009-08-09       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.